Clinical trials
Completed Phase 1 Immunoglobulin Light-chain Amyloidosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 3 |
| National Cancer Institute (NCI) | 3 |
| Northwestern University | 3 |
| University of Tennessee | 3 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Attralus, Inc. | 1 |
| California Cancer Consortium | 1 |
| Indiana University | 1 |
| M.D. Anderson Cancer Center | 1 |
| Mayo Clinic | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immunoglobulin Light-chain Amyloidosis | 23 |
| Burkitt Lymphoma | 13 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 13 |
| Lymphoma, Follicular | 13 |
| Lymphoma, Large B-Cell, Diffuse | 13 |
| Lymphoma, Large-Cell, Immunoblastic | 13 |
| Lymphoma, Mantle-Cell | 13 |
| Lymphoma, Non-Hodgkin | 13 |
| Multiple Myeloma | 13 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 13 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.